Zetia

Type: Product
Name: Zetia
First reported 8 hours ago - Updated 5 hours ago - 5 reports

Esperion shares rally on cholesterol drug study

By Wallace Witkowski, MarketWatchSAN FRANCISCO (MarketWatch) -- Shares of Esperion Therapeutics Inc. rallied after the drug developer said its treatment significantly lowered bad cholesterol in patients enrolled in a clinical trial. Esperion (ESPR) ... [Published Morningstar.com - 6 hours ago]
First reported Sep 29 2014 - Updated Sep 29 2014 - 1 reports

discount Zetia, Zetia, safe buy Zetia this

Order Zetia online without prescription!Zetia (Synonyms: Ezetimibe)order online Zetia... i need Zetia 10 mg, fda approved ZetiaZetia online rx... Zetia 10 mg best prices. Zetia no prior rx, order fast Zetia 10 mg, Zetia cod? Zetia to order, get cheap ... [Published Student Village - Sep 29 2014]
First reported Sep 28 2014 - Updated Sep 28 2014 - 2 reports

Zetia . Order Zetia No Prescription Required, Discount Online Zetia Cod

zetia . Order zetia no prescription required, discount online zetia codMed Portal has proved its reliability and safety, working at pharmaceutical market since 2003. One of the most urgent problems in online pharmacy business is the quality of the meds ... [Published Student Village - Sep 28 2014]
Entities: Zetia, Cheap, Discount
First reported Sep 22 2014 - Updated Sep 23 2014 - 1 reports

Does An Acquisition Of Sigma-Aldrich Make Merck Worth Considering?

Summary Merck announced Monday that it would acquire Sigma-Aldrich for $17 billion. The deal marks the largest takeover in Merck’s history, and it could be its most successful. Acquiring Sigma-Aldrich allows Merck to develop its chemicals business ... [Published Seeking Alpha - Sep 22 2014]
First reported Sep 02 2014 - Updated Sep 03 2014 - 1 reports

A new game-changing therapy in preventing heart disease? Regeneron and Sanofi think so.

In what may be the most important development in the management of coronary heart disease (CHD) since the discovery of statins, clinical trials of an antibody called alirocumab—which is being developed by Regeneron and Sanofi—have produced some astounding ... [Published American Council On Science & Health - Sep 02 2014]
First reported Aug 28 2014 - Updated Aug 28 2014 - 1 reports

3 Reasons Merck & Co., Inc.'s Stock Could Fall

If you were lucky enough to time your purchase of Merck ( NYSE: MRK     ) during the heights of the Great Recession, your investment has probably seen a return of 100% or greater. Unfortunately, timing the stock market is practically impossible to do, ... [Published Motley Fool Discussion Boards - Aug 28 2014]
First reported Aug 20 2014 - Updated Aug 20 2014 - 1 reports

A Cause for Celebration

Happy birthday to Al Roker, who makes even a rainy day forecast seem jolly.  Happy birthday to Amy Adams, who enchanted audiences in movies as diverse as Drop Dead Gorgeous , The Fighter , and American Hustle .  Happy birthday to the late Jacqueline ... [Published Drug and Device Law - Aug 20 2014]
First reported Aug 05 2014 - Updated Aug 05 2014 - 1 reports

Merck & Co posts net profit of $2,004 million in Q2

Merck & Co has registered strong growth in profits during the second quarter ended June 2014 despite lower sales. Its net profit increased by 121 per cent to $2,004 million from $906 million in the corresponding period of last year. However, its net sales ... [Published PharmaBiz - Aug 05 2014]
First reported Jul 29 2014 - Updated Jul 29 2014 - 1 reports

Merck 2Q profit more than doubles

A big one-time gain and a tax benefit helped drugmaker Merck & Co. more than double its second-quarter profit, raise the lower end of its profit forecast and easily top analysts' expectations. The maker of popular Type 2 diabetes pill Januvia and ... [Published The Washington Times stories: News - Jul 29 2014]
First reported Jul 10 2014 - Updated Jul 10 2014 - 1 reports

Why are doctors still prescribing Zetia?

A health research company just released a list of the 100 top drugs in America according to sales. 29th on the list, with sales of over $1.8 billion, is the cholesterol lowering drug ezetimibe, brand name Zetia. Continue reading ... Your patients ... [Published KevinMD.com - Jul 10 2014]
First reported Jul 08 2014 - Updated Jul 08 2014 - 1 reports

There They Go Again - Merck Threatened Legal Action Against Italian Doctor who Criticized Zetia

It seems that when confronted with unfavorable facts or opinions, Merck executives like to threaten legal action, rather than just argue their side of the case.  Last month we discussed how Merck officials used the US court system to try to prevent ... [Published Health Care Renewal - Jul 08 2014]
First reported Jul 07 2014 - Updated Jul 07 2014 - 1 reports

Larry Husten writes

Merck Uses Legal Threats To Stifle Negative Advice About Zetia And Vytorin In Italy In response to repeated legal threats, a public health doctor in Italy has withdrawn advice to curtail use of a controversial drug. The drug, ezetimibe, is a key ingredient ... [Published PharmaGossip - Jul 07 2014]

Quotes

"These are very encouraging results. It basically shows efficacy, and it shows that it can be added to ezetimibe to get more efficacy" Dr. Christie Ballantyne, chief of cardiology at Baylor College of Medicine in Houston and one of the study's investigators, said in a telephone inte...
Merck is paying somewhat of a premium for the company. According to Bloomberg , "The purchase values Sigma-Aldrich, excluding net debt, at about 19.9 times earnings before interest, taxes, depreciation and amortization for the past 12 months, compared with a median multiple of 9.5 times in specialty chemicals acquisitions of $100 million or more in the past five years." But the operating synergies and the functional expertise Sigma-Aldrich presents a solid value to Merck and its shareholders
...While other companies have had success buying clinical-stage hepatitis C drugs -- just look at Gilead Sciences " $11 billion purchase of Pharmasset, which yielded the now-blockbuster drug Sovaldi -- Idenix's pipeline has been riddled with disappointments throughout the years."
"Although we cannot comment on the likelihood of approval based solely on specific indications or populations" two drugs recently were approved based on cholesterol-lowering for people with inherited conditions, she noted

More Content

All (30) | News (24) | Reports (0) | Blogs (5) | Audio/Video (0) | Fact Sheets (1) | Press Releases (0)
sort by: Date | Relevance
Esperion shares rally on cholesterol drug study [Published Morningstar.com - 6 hours ago]
Esperion Reports Favorable Cholesterol Drug Dat... [Published 4 Traders - 7 hours ago]
UPDATE 1-Esperion drug succeeds in lowering LDL... [Published CNBC - 8 hours ago]
Esperion drug succeeds in lowering LDL choleste... [Published Yahoo! Finance UK and Ireland - 8 hours ago]
Esperion drug succeeds in lowering LDL choleste... [Published CNBC - 8 hours ago]
purchase Lithium Carbonate, Lithium Carbonate n... [Published Student Village - Sep 30 2014]
discount Zetia, Zetia, safe buy Zetia this [Published Student Village - Sep 29 2014]
Ceftin er generic, Ceftin prescription, purchas... [Published Student Village - Sep 29 2014]
ED Discount pack 1 vendre en ligne, ED Discount... [Published Student Village - Sep 29 2014]
online Differin, Differin no prior rx, Differin... [Published Student Village - Sep 29 2014]
Zetia . Order Zetia No Prescription Required, D... [Published Student Village - Sep 28 2014]
Cheap Zetia Cod, Buy Zetia Paypal Online Cash O... [Published Student Village - Sep 28 2014]
Does An Acquisition Of Sigma-Aldrich Make Merck... [Published Seeking Alpha - Sep 22 2014]
Sanofi: Riding The Growth Trend [Published Seeking Alpha - Sep 09 2014]
A new game-changing therapy in preventing heart... [Published American Council On Science & Health - Sep 02 2014]
Regeneron/Sanofi Presents Encouraging Alirocuma... [Published Zacks.com - Sep 02 2014]
Regeneron/Sanofi Presents Encouraging Alirocuma... [Published Zacks.com - Sep 02 2014]
Alirocumab bests ezetimibe for LDL reduction in... [Published Orthopedics Today - Aug 31 2014]
3 Reasons Merck & Co., Inc.'s Stock Could Fall [Published Motley Fool Discussion Boards - Aug 28 2014]
A Cause for Celebration [Published Drug and Device Law - Aug 20 2014]
Merck & Co posts net profit of $2,004 million i... [Published PharmaBiz - Aug 05 2014]
Merck 2Q profit more than doubles [Published The Washington Times stories: News - Jul 29 2014]
Why are doctors still prescribing Zetia? [Published KevinMD.com - Jul 10 2014]
There They Go Again - Merck Threatened Legal Ac... [Published Health Care Renewal - Jul 08 2014]
Larry Husten writes [Published PharmaGossip - Jul 07 2014]
Global Genomics Group ("G3") Appoints Harry "Ch... [Published PR Newswire: Health - May 06 2014]
Merck & Co net earnings moves up by 7% in Q1 [Published PharmaBiz - Apr 30 2014]
New drugs greatly lower cholesterol, studies show [Published Lehigh Valley Live - Mar 30 2014]
Patent expiration, stagnant R&D spend seriously... [Published PharmaBiz - Mar 28 2014]
Fact Sheet for Schering Plough Corporation [Published Able2Act - Jan 09 2008]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
A Cause for Celebration [Published Drug and Device Law - Aug 20 2014]
Happy birthday to Al Roker, who makes even a rainy day forecast seem jolly.  Happy birthday to Amy Adams, who enchanted audiences in movies as diverse as Drop Dead Gorgeous , The Fighter , and American Hustle .  Happy birthday to the late Jacqueline ...
Why are doctors still prescribing Zetia? [Published KevinMD.com - Jul 10 2014]
A health research company just released a list of the 100 top drugs in America according to sales. 29th on the list, with sales of over $1.8 billion, is the cholesterol lowering drug ezetimibe, brand name Zetia. Continue reading ... Your patients ...
There They Go Again - Merck Threatened Legal Ac... [Published Health Care Renewal - Jul 08 2014]
It seems that when confronted with unfavorable facts or opinions, Merck executives like to threaten legal action, rather than just argue their side of the case.  Last month we discussed how Merck officials used the US court system to try to prevent ...
Larry Husten writes [Published PharmaGossip - Jul 07 2014]
Merck Uses Legal Threats To Stifle Negative Advice About Zetia And Vytorin In Italy In response to repeated legal threats, a public health doctor in Italy has withdrawn advice to curtail use of a controversial drug. The drug, ezetimibe, is a key ingredient ...
Global Genomics Group ("G3") Appoints Harry "Ch... [Published PR Newswire: Health - May 06 2014]
RICHMOND, Va., May 6, 2014 /PRNewswire/ -- Global Genomics Group (G3), a life sciences company investigating biological networks that lead to the development of disease to identify novel diagnostic biomarkers and therapeutic targets, today announced the ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.